0 Yorumlar
0 hisse senetleri
535 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Dopamine Beta Hydroxylase Deficiency Market Size, Share, Industry Trends, Growth Drivers and Forecast Report 2026–2033" According to the latest report published by Data Bridge Market Research, the Dopamine Beta Hydroxylase Deficiency Market The dopamine beta hydroxylase deficiency market is expected to witness market growth at a rate of 6.00% in the forecast period of 2022 to 2029. Dopamine Beta Hydroxylase Deficiency Market research report has been structured. The report assesses ongoing as...0 Yorumlar 0 hisse senetleri 27 Views 0 önizleme
-
Emerging Demands in the Global Non-Cardioselective Beta Blockers Market: Comprehensive Segment Analysis and Forecast, 2026-2033According to the latest report published by Data Bridge Market Research, the Non-Cardioselective Beta Blockers Market The global non-cardioselective beta blockers market size was valued at USD 3.50 billion in 2025 and is expected to reach USD 5.09 billion by 2033, at a CAGR of4.80% during the forecast period A number of aspects that are kept into view while creating an...0 Yorumlar 0 hisse senetleri 210 Views 0 önizleme
-
Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market Share and Size Report, Emerging Trends and Forecast Analysis"Executive Summary Europe Alpha and Beta Emitters Based Radiopharmaceuticals Market Research: Share and Size Intelligence The Europe alpha and beta emitters based radiopharmaceuticals market size was valued at USD 215.99 million in 2024 and is expected to reach USD 465.84 million by 2032, at a CAGR of 10.1% during the forecast period The all-inclusive Europe Alpha...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
GSK-3β Inhibitors Therapeutics Market Report: Drug Discovery Trends"According to the latest report published by Data Bridge Market Research, the Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market The global glycogen synthase kinase 3 beta (GSK-3β) inhibitors therapeutics market size was valued at USD 2.19 billion in 2024 and is projected to reach USD 3.29 billion by 2032, with a CAGR of 5.20% during the forecast period...0 Yorumlar 0 hisse senetleri 11 Views 0 önizleme
-
TGF-β Pathway Targeted Anti-Fibrotic Drug Market Trends Driving Future Industry Growth"According to the latest report published by Data Bridge Market Research, the TGF-β Pathway Targeted Anti-Fibrotic Drug Market The global TGF-β Pathway Targeted Anti-Fibrotic Drug market size was valued at USD 2.18 billion in 2025and is expected to reach USD 7.86 billion by 2033, at a CAGR of 17.40% during the forecast period. The persuasive TGF-β...0 Yorumlar 0 hisse senetleri 284 Views 0 önizleme
-
The "Viral Frontier": Is 2026 the Year Interferon Beta Moves Beyond MS?A major shift in the 2026 global industry is the record-breaking research into "Interferon-Based Antivirals." This year, to cater to "Pandemic Preparedness" initiatives, the Interferon Beta Drugs Market is exploring Intranasal Prophylactics to fight off respiratory viral threats. This level of "Emergency Versatility" is the new frontier, expanding the use of these drugs from specialized...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek